Evaluation of Clinical Perfectionism in Parkinson Disease (EPMP-1)
Primary Purpose
Parkinson Disease
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Completion of scales evaluation
Sponsored by
About this trial
This is an interventional other trial for Parkinson Disease focused on measuring Parkinson, Perfectionism
Eligibility Criteria
Inclusion Criteria:
- Age greater than 18 years
- Score Mini Mental Scale (MMS) greater than 23
- For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
- The control patients present dystonias not within the scope of Parkinson
- Informed Consent Form signed
- Patient covered by social insurance
Exclusion Criteria:
- Proven Presence of neuropsychological disorders
- Patients with deep brain stimulation
- Diagnosis of somatic pathology diagnosed
- Private Patient freedom or protected adult (under guardianship)
Sites / Locations
- CHU Amiens
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Parkinsonian
Dystonic
Arm Description
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Outcomes
Primary Outcome Measures
Perfectionism evaluation 1
Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)
Perfectionism evaluation 2
Hewitt Multidimensional Perfectionism Scale (HMPS).
Secondary Outcome Measures
Depression and anxiety evaluation 1
Scores to depression scale (Beck Depression Inventory (BDI))
Depression and anxiety evaluation 2
anxiety scale (State Trait Anxiety Inventory (STAI))
Full Information
NCT ID
NCT02824367
First Posted
April 22, 2014
Last Updated
August 20, 2018
Sponsor
Centre Hospitalier Universitaire, Amiens
1. Study Identification
Unique Protocol Identification Number
NCT02824367
Brief Title
Evaluation of Clinical Perfectionism in Parkinson Disease
Acronym
EPMP-1
Official Title
Evaluation of Clinical Perfectionism in Parkinson Disease
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 6, 2014 (Actual)
Primary Completion Date
August 2018 (Anticipated)
Study Completion Date
August 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire, Amiens
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.
Detailed Description
Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).
To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.
The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
Parkinson, Perfectionism
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Parkinsonian
Arm Type
Other
Arm Description
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Arm Title
Dystonic
Arm Type
Other
Arm Description
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Intervention Type
Behavioral
Intervention Name(s)
Completion of scales evaluation
Intervention Description
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))
Primary Outcome Measure Information:
Title
Perfectionism evaluation 1
Description
Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)
Time Frame
Day 0
Title
Perfectionism evaluation 2
Description
Hewitt Multidimensional Perfectionism Scale (HMPS).
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Depression and anxiety evaluation 1
Description
Scores to depression scale (Beck Depression Inventory (BDI))
Time Frame
Day 0
Title
Depression and anxiety evaluation 2
Description
anxiety scale (State Trait Anxiety Inventory (STAI))
Time Frame
Day 0
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age greater than 18 years
Score Mini Mental Scale (MMS) greater than 23
For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
The control patients present dystonias not within the scope of Parkinson
Informed Consent Form signed
Patient covered by social insurance
Exclusion Criteria:
Proven Presence of neuropsychological disorders
Patients with deep brain stimulation
Diagnosis of somatic pathology diagnosed
Private Patient freedom or protected adult (under guardianship)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre KRYSTKOWIAK, MD, PhD
Organizational Affiliation
CHU Amiens
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Amiens
City
Amiens
ZIP/Postal Code
80054
Country
France
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Clinical Perfectionism in Parkinson Disease
We'll reach out to this number within 24 hrs